Monday, 20 May 2019

Drug Discovery News

  • Low R&D output, patent cliffs drives big pharma nuts

    Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

    Singapore: According to the latest global report from industry experts, GBI Research, low R&D productivity, combined with the patent cliff and a stringent US FDA approval process, is re...Read more

  • Bayer, Compugen enter $500 mn cancer deal

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

    Singapore: Israel-based Compugen and global pharmaceutical company Bayer are to jointly pursue a preclinical research program for research, development, and commercialization of antibody-ba...Read more

  • Taiho to start ph III trial in colorectal cancer

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 31 May, 2012

    Singapore: Japan based-Taiho Pharmaceutical is starting global phase III clinical trial (RECOURSE) for the novel combination antimetabolite TAS-102 in June this year. RECOURSE is a randomi...Read more

  • FDA nod for Genentech pre-surgical cancer drug

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

    Singapore: Genentech, a member of the Roche Group, has recieved US FDA approval for Perjeta (pertuzumab) regimen for neoadjuvant treatment (use before surgery) in people with high-risk, HER...Read more

  • FDA issues complete response letter for PREZISTA

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 31 May, 2012

    Singapore: The US Food and Drug Administration (FDA) has issued a complete response letter to Janssen Therapeutics for Supplemental New Drug Application (sNDA) for an 800mg tablet of PREZI...Read more

  • Pharma majors join hands to find new cure for TB

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jun, 2012

    Seven pharmaceutical companies and four research institutions, working with the Bill & Melinda Gates Foundation, recently launched a partnership that aims to speed the discovery of esse...Read more

  • GSK to publish clinical study reports of drugs

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 07 Feb, 2013

    Singapore: Demonstrating its commitment to clinical trial transparency, multinational pharmaceutical company GlaxoSmithKline has announced its support for the AllTrials campaign. The campa...Read more

  • Ex-sanofi cancer head is PharmaEngine advisor

    Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 05 Mar, 2013

    Singapore: Taiwan's PharmaEngine appointed Dr Alain Herrera as senior advisor for clinical strategy, operations, corporate strategy, licensing and alliance management. Dr Herrera previousl...Read more

  • Cold Spring Harbor Lab uses cancer drugs to treat Alzheimer's

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 26 Sep, 2012

    Singapore: A team of American and Chinese neuroscientists at the Cold Spring Harbor Laboratory (CSHL) have carried out research to show that a class of currently used anti-cancer drugs as w...Read more

  • Chugai expands in Singapore with research institute

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2012

    Singapore: Japan's Chugai Pharmabody Research (CPR) has started its operations in Singapore. The company started operations in Singapore on July 2, 2012. The opening ceremony was attended b...Read more

  • Australia invests in autoimmune disease start up firm

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Helmedix, an early stage biopharmaceutical company developing novel therapies for autoimmune and inflammatory diseases such as rheumatoid arthritis, colitis, psoriasis and multip...Read more

  • François-Xavier Roge is Takeda's new CFO

    Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 28 Aug, 2013

    Singapore: Japan-headquartered global firm, Takeda Pharmaceutical, appointed Mr François-Xavier Roger as its chief financial officer (CFO), effective September 2, 2013.In his new role, M...Read more

  • Novartis, Regenerex further immune tolerance R&D

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2013

    Singapore: Novartis entered into an exclusive global licensing and research collaboration agreement with Regenerex, a biopharmaceutical company based in Louisville, Kentucky, US, for use of...Read more

  • Boehringer Ingelheim appoints board member

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jul, 2012

    Singapore: The shareholders of Boehringer Ingelheim have appointed Dr Joachim Hasenmaier to Boehringer Ingelheim's board of managing directors. The 52-year-old will take over the responsibi...Read more

  • China develops revolutionary TCM migraine medication

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2012

    Singapore: China Health Resource (CHRI) has developed a revolutionary TCM migraine medication called Toufeng Migraine tablet, which demonstrated an effective rate of 96.5 percent in clinica...Read more

  • Novartis eye care firm gets EU nod for Jetrea

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2013

    Singapore: Alcon, the global leader in eye care and a division of Novartis, has received European Commission's approval for Jetrea intravitreal injection (ocriplasmin) in the EU for the tre...Read more

  • QRxPharma to resubmit NDA to FDA for pain relieving drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Australia's QRxPharma has received Complete Response Letter (CRL) from USFDA for its MOXDUO New Drug Application (NDA) for treatment of moderate to severe acute pain.With the iss...Read more

  • Gilead HIV/AIDS 'blood booster' gets EU nod

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 26 Sep, 2013

    Singapore: Gilead Sciences has recieved European Commission marketing authorization approval for once-daily Tybost (cobicistat 150 mg tablets), a pharmacokinetic enhancer that boosts blood ...Read more

Podcast

 

Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls